New technique kills cancer virus without harming healthy cellsSeptember 03, 2002Major breakthrough could lead to successful treatment of viral cancers, without side-effects. Yorkshire Cancer Research funded researchers at the University of York have made a major cancer breakthrough. Using a new technique called RNA interference, they have successfully killed human cervical cancer cells grown in culture without causing damage to healthy cells. The discovery could have major implications, potentially leading to the successful treatment of cancers caused by viral infection without any harmful side effects. The research, carried out by Professor Jo Milner and Dr Ming Jiang, is the first of its kind to use RNA interference to attack cancerous cells. The impact of the technique - the total elimination of all cancerous cells - was unexpected. "Our work has identified a novel agent with major therapeutic potential for the treatment, and possibly also the prevention, of human cervical cancer," said Professor Jo Milner. Human cervical cancer, caused by viral infection, is the second most common form of cancer in women worldwide and kills around 1,250 women in the UK alone each year. Cervical cancer develops when the virus attacks the body`s two front lines of defence - its two tumour suppressors, the proteins p53 and RB. In normal cells RB controls cell division, whilst p53 has the ability to kill damaged cells that might become cancerous. The virus attacks both these proteins and takes over the reins of cells growth, driving continual out-of-control cell proliferation. Dr Jiang and Professor Milner wanted to know if the use of RNA interference - never before used on mammalian cells - could knock out viral genes in the infected cells and restore the body`s normal defence mechanism. The silencing of one viral gene - HPV E6 - caused the growth of the tumour cells to slow and some cells died. Remarkably, when the second viral gene was silenced (HPV E7 gene), all the cancer cells died. Using RNA interference, the infected cells died by a regulated process known as ‘apoptosis`, which enables cells to be removed without inflammatory side-effects. It was important, however, to establish that normal healthy cells remained unaffected. In control experiments, researchers found that the anti-viral treatment had no effect on the normal growth and behaviour of non-infected human cells. The successful elimination of cancer cells without adverse effects on normal cells was described by Professor Jo Milner as "absolutely remarkable". "These cancer cells were not engineered in the laboratory. They were derived from a human tumour many years ago. Despite growing as cancer cells for years (due to the viral infection) our work demonstrates that the cells` normal control systems have remained intact. As soon as we silenced the viral genes, the infected cancer cells ‘committed suicide`." Elaine King, Chief Executive of Yorkshire Cancer Research, the charity which funded the research said: "This really is encouraging news and proves once again that the research we fund in Yorkshire really is world class. The hard work and dedication of Yorkshire Cancer Research funded scientists is unwavering and it is this on-going research process that brings about these breakthroughs. While such breakthroughs, by their nature, don`t happen every day, it is crucial that we continue to fund research, for which we continue to rely on the generosity of the people of Yorkshire." "I would like to offer my sincere congratulations to Professor Milner, Dr Jiang and their team at York and my thanks to our supporters who have made it all possible." Professor Milner and Dr Jiang are now working on other types of tumours to see if the technique is as effective. Meanwhile, researchers in the United States have found that RNA interference is showing promising results in protecting cells from infection with the HIV virus, signalling that many types of human viral infection could be cured in the future by drugs based on the technique. | |||||||||||||||||||||
|
Related Cervical Cancer Current Events and Cervical Cancer News Articles LSUHSC public health contributes to estimate of HPV-related cancers Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date. The health burden of raising a grandchild Precautionary health measures such as mammograms and cholesterol tests that identify the risk of heart disease are critical for the well-being of women over 50. Add the responsibility of providing sustained care for a grandchild, and these preventive examinations become even more important. Healthy bones program reduces hip fractures by 37 percent Proactive measures can reduce hip fracture rates by an average of 37.2 percent -- and as much as 50 percent -- among those at risk, according to a study conducted by Kaiser Permanente Southern California. The study was published online on November 3 by The Journal of Bone & Joint Surgery, a peer-reviewed journal. New MRI technique may identify cervical cancer early Using high-resolution magnetic resonance imaging (MRI) with a special vaginal coil, a technique to measure the movement of water within tissue, researchers may be able to identify cervical cancer in its early stages, according to a new study being published in the November issue of Radiology. Cancer screening rates among older Medicaid patients fall short of national objectives Only about half of Medicaid recipients age 50 and older appear to receive recommended screening tests for colorectal, breast and cervical cancer, according to a report in the October 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Social class dictates cancer risk Cervical and lung cancer are more common in poor people while rates of breast cancer and melanoma are higher in the wealthy. Model highlights benefits and risks of cervical cancer screening methods In an analysis based on a computer model, it appears that comparing the benefits and risks of different cervical cancer prevention approaches may help women and their physicians choose appropriate screening strategies. New HPV test for developing countries shows high accuracy in predicting cervical disease: Study A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries. As head and neck cancer risks evolve, more treatment options emerge Advances in understanding head and neck cancer over the last decade have led to more treatment options and improved quality of life for patients, according to a review published this week in the New England Journal of Medicine. Cervical cancer prevention should focus on vaccinating adolescent girls The cost-effectiveness of vaccination in the United States against human papillomavirus (HPV), a sexually-transmitted virus that causes cervical cancer, will be optimized by achieving universal vaccine coverage in young adolescent girls, by targeting initial "catch-up" efforts to vaccinate women younger than 21 years of age, and by revising current screening policies. More Cervical Cancer Current Events and Cervical Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||